Live Quote · NYSECORHealthcare· Medical - Distribution

Cencora, Inc.

$296.51 2.80%(+$8.09)
TickerSpark Score
59/100
Mixed
80
Valuation
55
Profitability
60
Growth
52
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a COR research report →

52-Week Range39% of range
Low
$244.82
Current
$296.51
High
$377.54
Company Overviewwww.cencora.com

About the company

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.

CEO
Robert Mauch
IPO
1995
Employees
47,000
HQ
Conshohocken, PA, US

Price Chart

+1.83% · this period
$374.75$313.75$252.74Jul 02Dec 31Jul 02
Valuation
Market Cap
$57.69B
P/E
22.60
P/S
0.18
P/B
16.98
EV/EBITDA
13.58
Div Yield
0.79%
Profitability
Gross Margin
3.47%
Op Margin
1.28%
Net Margin
0.78%
ROE
115.93%
ROIC
11.89%
Growth & Income
Revenue
$321.33B · 9.31%
Net Income
$1.55B · 2.99%
EPS
$8.02 · 5.53%
Op Income
$3.65B
FCF YoY
6.99%
Performance & Tape
52W High
$377.54
52W Low
$244.82
50D MA
$279.27
200D MA
$324.29
Beta
0.59
Avg Volume
1.77M

Get TickerSpark's AI analysis on COR

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 29, 26Boratto Eva Cother21,304
Jun 29, 26Boratto Eva Cother0
Jun 29, 26Boratto Eva Cother0
Jun 22, 26Tyler Lauren Mbuy550
Jun 18, 26DURCAN DERMOT MARKbuy4,000
May 28, 26DURCAN DERMOT MARKbuy4,000
May 1, 26Tyler Lauren Mother99
May 1, 26Cooper Ellenother99
May 1, 26NALLY DENNIS Mother116
Apr 1, 26Krikorian Lazarusother3,936
Coverage · COR

Our COR coverage

Recent articles, reports, and earnings notes.

View all →
For Active Investors

Want a deeper read on COR?

Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.

Generate COR report →
Internal Compare

Similar companies

Peers in the same neighborhood.